Common Î³-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Massoud, Raya; Enose-Akahata, Yoshimi; Tagaya, Yutaka; Azimi, Nazli; Basheer, Asjad; Jacobson, Steven

Massoud, Raya; Enose-Akahata, Yoshimi; Tagaya, Yutaka; Azimi, Nazli; Basheer, Asjad; Jacobson, Steven.

Afiliación

Massoud R; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
Enose-Akahata Y; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
Tagaya Y; Cell Biology Laboratory, Division of Basic Science and Vaccine Research, University of Maryland School of Medicine, Baltimore, MD 21201;
Azimi N; Bioniz, LLC, Irvine, CA 92618.
Basheer A; Bioniz, LLC, Irvine, CA 92618.
Jacobson S; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892; jacobsons@ninds.nih.gov.

Proc Natl Acad Sci U S A ; 112(35): 11030-5, 2015 Sep 01.

Article en En | MEDLINE | ID: mdl-26283355

Asunto(s)

Biomarcadores/metabolismo; Paraparesia Espástica Tropical/inmunología; Péptidos/farmacología; Degranulación de la Célula/efectos de los fármacos; Humanos; Técnicas In Vitro; Linfocitos T/efectos de los fármacos

Palabras clave

HAM/TSP; IL-15; gamma chain; human T-cell lymphotropic virus type 1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Biomarcadores / Paraparesia Espástica Tropical Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google